Universal eryhrodermia, KELA reimbursement

No definition available.

Endpoint definition

↥
FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

KELA reimbursements: KELA codes 134

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector L12_ERYTHRO_KELA

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 215 80 135
Unadjusted prevalence (%) 0.08 0.05 0.12
Mean age at first event (years) 48.64 45.69 50.39

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.01 0.88 [0.29, 2.66] 8.2e-1 22
15 years 0.01 0.97 [0.35, 2.73] 9.6e-1 13
5 years - - - -
1 year - - - -

Correlations

↥

Index endpoint: L12_ERYTHRO_KELA – Universal eryhrodermia, KELA reimbursement
GWS hits: 2

Survival analyses between endpoints

↥

Plot

before Universal eryhrodermia, KELA reimbursement
after Universal eryhrodermia, KELA reimbursement

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Universal eryhrodermia, KELA reimbursement

↥